Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,030,716
+$1,310,916 QoQ
Shares Held
7,481
+138.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#364
of 844 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Curi Capital, LLC holds $118,928,378 across 14 Diagnostics & Research names. NTRA ranks #5 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
263,989 | $50,284,624 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
59,496 | $31,321,073 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
53,292 | $26,718,476 | |
| 4 | VCYT |
Veracyte, Inc.
|
63,197 | $3,711,559 | |
| 5 | NTRA |
Natera, Inc.
This page
|
7,481 | $2,030,716 | |
| 6 | NEO |
Neogenomics Inc
|
86,132 | $1,256,665 | |
| 7 | ILMN |
Illumina, Inc.
|
5,756 | $1,012,077 | |
| 8 | GRAL |
GRAIL, Inc.
|
9,006 | $614,838 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,030,716 | 7,481 | Shares | Other | 2026-08-14 | |
| 2025-12-31 | $719,800 | 3,142 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||